MFS
CTXR icon

Miller Financial Services’s Citius Pharmaceuticals CTXR Stock Holding History

Miller Financial Services’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.6K Buy
130,000
+116,000
+829% +$78.5K 0.06% 138
2026
Q1 		$12.6K Buy
+14,000
New +$11.3K 0.01% 118

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
BW
BostonPremier Wealth Hanover, Massachusetts $235M AUM 31.01% 1-Year Est. Return

Miller Financial Services's CTXR Position: Q2 2026 in Review

Miller Financial Services increased its Citius Pharmaceuticals (CTXR) stake by 829% in Q2 2026, buying an estimated $78.5K and bringing the position to 130,000 shares worth $78.6K. The position accounts for 0.06% of the portfolio, ranked #138.

Miller Financial Services first reported a position in CTXR in Q1 2026 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Miller Financial Services held 130,000 shares of Citius Pharmaceuticals worth $78.6K as of Q2 2026.
  • Miller Financial Services bought 116,000 Citius Pharmaceuticals shares in Q2 2026, an estimated $78.5K.
  • Citius Pharmaceuticals made up 0.06% of Miller Financial Services's portfolio in Q2 2026, its #138 holding.
  • Miller Financial Services first reported a position in Citius Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Miller Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.